Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Impact in
- Immunology 1.7k
- Oncology 1.2k
Classified as
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm1622 →Countries where authors are citing Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
This map shows the geographic impact of Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy more than expected).
Fields of papers citing Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
This network shows the impact of Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
About Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
This paper, published in 2007, received 2.7k indexed citations . Written by Lionel Apétoh, François Ghiringhelli, Antoine Tesnière, Michel Obéid, Carla Ortiz, Alfredo Criollo, Grégoire Mignot, Maria Chiara Maiuri, Evelyn Ullrich and Patrick Saulnier covering the research area of Immunology. It is primarily cited by scholars working on Immunology (1.7k citations), Oncology (1.2k citations), Molecular Biology (518 citations), Pulmonary and Respiratory Medicine (224 citations) and Biomedical Engineering (197 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm1622.